7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Courteix, C; Eschalier, A; Lavarenne, J | 1 |
1 other study(ies) available for 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one and Asymmetric Diabetic Proximal Motor Neuropathy
Article | Year |
---|---|
RP-67580, a specific tachykinin NK1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats.
Topics: Analgesics; Analysis of Variance; Animals; Diabetic Neuropathies; Hyperalgesia; Indoles; Isoindoles; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Stereoisomerism; Substance P | 1993 |